跳至主要内容
临床试验/CTRI/2020/08/027083
CTRI/2020/08/027083已完成未知

Real world experience about efficacy and safety of Giloy Gomutra (Cow Urine), Asthi Churna and Kamdhenu Asava in the management of COVID-19 in Indian setting. (REAL Giloy Gomutra, Asthi Churna and Kamdhenu Asava Product)

Bansi Gir Gaushala0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Treating physician had to agree to provide information regarding the Patients who have been diagnosed with Covid-19 with mild and moderate symptoms.

排除标准

  • Patient having severe symptoms will not be included in the study
  • Any condition that according to the discretion of the investigator indicate that the patient is not suitable for inclusion in the study

研究者

发起方
Bansi Gir Gaushala

相似试验